Electrical Management of the Cardiomyopathies: Amyloidosis, ARVC & DSP Cardiomyopathies, Sarcoidosis, and Hypertrophic Cardiomyopathy

Description

The goal of this session is to provide an overview on the predominant arrhythmias and management approaches for the various cardiomyopathies. In particular, there will be review of guidelines-based recommendations for ablation and appropriate device selection. Discussion will be case-based--highlighting how to approach diagnosis, work-up, and make specific treatment recommendations through case examples.

Learning Objectives

Evaluate the incidence and type of arrhythmias in different cardiomyopathy populations.
Summarize the use and evidence for ablation in the treatment of arrhythmias in cardiomyopathy.
Outline the use and evidence for specific device-selection in cardiomyopathy.

Session Chair(s)

Babak Nazer, MD
Kelly Arps, MD

Presentation

Medical Advances in Cardiac Amyloidosis and Impact on Arrhythmia Care
Presenter(s): Matthew Timothy. Brown, BSE, MD

Arrhythmia Management in ARVC and DSP Cardiomyopathy
Presenter(s): Klitos Konstantinidis

Diagnostic Uncertainy and Ventricular Arrhythmias in Cardiac Sarcoidosis
Presenter(s): Neal Chatterjee, MD, MS

Arrhythmia Management in Hypertrophic Cardiomyopathy
Presenter(s): Lohit Garg, MBBS, MD

Disclosures

Matthew Brown:

Nothing Relevant to Disclose

Klitos Konstantinidis:

Nothing Relevant to Disclose

Neal Chatterjee:

Nothing Relevant to Disclose

Lohit Garg:

Abbott Medical (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Other Arrhythmia Syndromes
-- Arrhythmogenic Cardiomyopathies
-- 269. Know the broad spectrum of genetic, systemic, infectious, and inflammatory disorders that make up the arrhythmogenic cardiomyopathies, including hypertrophic cardiomyopathy, arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas Disease, left ventricular noncompaction and muscular dystrophies.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered